Immuron Limited Gains 24.78%
Tue, Jan 18, 2022 at 05:30 PM
Immuron Limited (IMRN:NASDAQ) rocketted at $4.23, representing a gain of 24.8%. The stock appeared on our News Catalysts scanner on Fri, Jan 14, 2022 at 03:21 PM in the 'MISCELLANEOUS' category. From Fri, Dec 31, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Sep 24, 2021 at $5.2 with a volume of 1M+.
About Immuron Limited (IMRN:NASDAQ)
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Top 10 Gainers:
- Brickell Biotech, Inc. (BBI:NASDAQ), 58.58%
- DatChat Inc. (DATS:NASDAQ), 38.75%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 31.1%
- NeuroMetrix, Inc. (NURO:NASDAQ), 29.47%
- Mainz Biomed B.V. (MYNZ:NASDAQ), 27.89%
- Vinco Ventures Inc. (BBIG:NASDAQ), 27.52%
- Activision Blizzard, Inc. (ATVI:NASDAQ), 25.88%
- Immuron Limited (IMRN:NASDAQ), 24.78%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 20.29%
- Integrated Media Technology Limited (IMTE:NASDAQ), 19.95%